07:00 , May 22, 2014 |  BC Innovations  |  Distillery Therapeutics

Indication: Neurology

Indication Target/marker/pathway Summary Licensing status Publication and contact information Neurology Depression; psychosis Serotonin (5-HT6) receptor; serotonin (5-HT7) receptor; dopamine D2 receptor In vitro and rat studies suggest inhibitors of 5-HT6, 5-HT7 and dopamine D2 receptors...